MNIVF (Monash IVF Group) LT-Debt-to-Total-Asset: 0.37 (As of Dec. 2025)

What is Monash IVF Group LT-Debt-to-Total-Asset?

Monash IVF Group MNIVF 78 LT-Debt-to-Total-Asset is 0.37 as of Dec. 2025. GuruFocus rates MNIVF with a GF Score™ of 78/100 and a GF Value™ of $0.78. The stock has 8 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Monash IVF Group's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.37.

Monash IVF Group's long-term debt to total assets ratio increased from Dec. 2024 (0.29) to Dec. 2025 (0.37). It may suggest that Monash IVF Group is progressively becoming more dependent on debt to grow their business.

Monash IVF Group (OTCPK:MNIVF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Monash IVF Group LT-Debt-to-Total-Asset Related Terms

Monash IVF Group LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Monash IVF Group's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Monash IVF Group LT-Debt-to-Total-Asset Chart

Monash IVF Group Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.11

0.21

0.22

0.25

0.35

Monash IVF Group Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.16	0.25	0.29	0.35	0.37

78GF Score

Monash IVF Group Ltd MNIVF

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Monash IVF Group LT-Debt-to-Total-Asset Calculation

Monash IVF Group's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2025 is calculated as

LT Debt to Total Assets (A: Jun. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Jun. 2025 )	/	Total Assets (A: Jun. 2025 )
	=	110.878	/	320.708
	=	0.35

Monash IVF Group's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )	/	Total Assets (Q: Dec. 2025 )
	=	124.074	/	339.01
	=	0.37

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.37 mean?

Monash IVF Group (MNIVF) has a LT-Debt-to-Total-Asset of 0.37 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Monash IVF Group and its competitors.

Is Monash IVF Group's LT-Debt-to-Total-Asset too high?

Monash IVF Group's current LT-Debt-to-Total-Asset is 0.37. Overall, Monash IVF Group has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.

How does Monash IVF Group's LT-Debt-to-Total-Asset compare to TMO and DHR?

Monash IVF Group's LT-Debt-to-Total-Asset of 0.37 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Medical Diagnostics & Research company?

A good LT-Debt-to-Total-Asset depends on the Medical Diagnostics & Research industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Monash IVF Group and its competitors. Monash IVF Group's current LT-Debt-to-Total-Asset is 0.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Monash IVF Group stock overvalued right now?

Monash IVF Group (MNIVF) has a current LT-Debt-to-Total-Asset of 0.37. The stock's GF Value™ is $0.78, compared to a current price of $0.40 — trading 48.7% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.37. Monash IVF Group's overall GF Score™ is 78/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Monash IVF Group (MNIVF), the current LT-Debt-to-Total-Asset is 0.37 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Monash IVF Group (MNIVF) Overvalued in 2026?

Based on GuruFocus' analysis, Monash IVF Group stock appears to be undervalued. The current stock price of $0.40 is trading 48.7% below its estimated GF Value™ of $0.78.

Key valuation signals for MNIVF:

LT-Debt-to-Total-Asset: 0.37
GF Value™: $0.78 vs. price of $0.40 (48.7% below fair value)
GF Score™: 78/100 with 8 warning signs

No single metric tells the full story. See the MNIVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Monash IVF Group Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies ASX:HLS ASX:ACL ASX:IIQ ASX:CTE ASX:RHY ASX:BDX ASX:MAP ASX:IME ASX:GSS ASX:IBX TMO DHR SHSE:603259 XSWX:LONN IDXX A NTRA WAT IQV ILMN

Other Exchanges MVF:Australia

Address 510 Church Street, Level 1, Cremorne, VIC, AUS, 3121

Website https://www.monashivfgroup.com.au

Monash IVF Group Ltd is a provider of fertility services, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The Group operates two main segments: Australia IVF and Ultrasound, which offer ARS, ultrasound, and related women's health services, and International IVF, which provides assisted reproductive care in South East Asia. The majority of revenue is generated from the Australian segment through its brands such as Fertility Solutions, KL Fertility, Monash IVF, Repromed, and others.

78GF Score

Get the complete analysis for MNIVF

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.40

Price

$0.78

GF Value

View MNIVF Analysis

See LT-Debt-to-Total-Asset data for all stocks →